tirzepatide off shortage Update: On December 19th the FDA ruled the tirzepatide was resolved, however is giving a grace period for compounding pharmacies to continuing manufacturing. This grace period is 60 days. On Drugmakers battle pharmacies over compounded

Depressive-like behavior - In male rats, supplementation with N-3 PUFAs (postnatal day (P)41-61) [41] or sodium butyrate (P60-67) [42] mitigated the postnatal stress (POS)-induced depressive-like behavior in the forced swim test (FST) at two months of age [41] and at P67 [42]

More than 20 million Americans go on a fad diet every year

In a pool of placebo-controlled trials, gastrointestinal adverse effects occurred in more than 5% of patients taking tirzepatide

For those on TRT, addressing fat mass can minimize estrogen excess and reduce the need for higher testosterone doses or additional medications

GLP-1 medications present a unique calcium concern

The side effects of these supplements arent well-documented and can look different for everybody